Lundbeck South Africa (SA) is a subsidiary of H. Lundbeck A/S, an international, Danish, research-based pharmaceutical company focusing on the Central Nervous System.
Established in 1984 and based in Johannesburg, Lundbeck SA has been part of the South African pharmaceutical industry for almost three decades and researches and markets products for Depression, Anxiety, Alzheimer’s disease, Parkinson’s disease and Schizophrenia.
As a specialist in psychiatry and pioneer in neurology, Lundbeck is committed to the education and support of doctors and patients. To date, with the assistance of psychiatrists and neurologists, Lundbeck SA has trained more than 6000 general practitioners in the treatment of Depression, Anxiety, Alzheimer’s disease and Parkinson’s disease.
Lundbeck SA also provides educational materials for specialists, their patients and relatives and caregivers by way of information booklets, meetings and the Lundbeck mySupport online programme. In this way Lundbeck is fulfilling its mission to improve the quality of life for those suffering from psychiatric and neurological disorders. At Lundbeck we believe that our contribution to a mentally healthy South Africa is fundamental to our purpose.